검색어 : 통합검색[Orr Rebecca B.]
총 76건 중 76건 출력
, 4/8 페이지
-
31
- Abstract OT1-1-16: A randomized, multicenter, phase II study of ipatasertib (Ipat, GDC-0068), an inhibitor of Akt, in combination with paclitaxel (Pac) as front-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC)
- Isakoff, Steven J; Kim, Sung-Bae; Im, Seock-Ah; Dent, Rebecca A; Traina, Tiffany A; Valero, Vicente; Saura, Cristina; Yalamanchili, Sreeni; Patel, Premal; Oliveira, Mafalda; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.75, 2015, pp.OT1-1-16-OT1-1-16)
-
32
- Abstract PO1-20-13: TROPION-Breast04: A phase 3 study of neoadjuvant datopotamab deruxtecan (Dato-DXd) + durvalumab followed by adjuvant durvalumab vs the standard of care in treatment-naive early-stage triple negative or HR-low/HER2- breast cancer
- McArthur, Heather; Tolaney, Sara; Loibl, Sibylle; Dent, Rebecca; Schmid, Peter; Asselah, Jamil; Song, Erwei; Niikura, Naoki; 1UT Southwestern, Dallas, Texas, United States; ; 2Dana-Farber Cancer Institute, Boston, Massachusetts, United States; ; 3German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany, Neu-Isenburg, Hessen, Germany; ; 4National Cancer Centre Singapore, Singapore; ; 5Barts Cancer Institute, Queen Mary University London, London, England, United Kingdom; ; 6McGill University Health Centre, Montreal, Quebec, Canada; ; 7Breast Tumour Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; ; 8Tokai University School of Medicine, Isehara-shi, Isehara, Kanagawa, Japan; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.PO1-20-13-PO1-20-13)
-
33
- Abstract 379: Landscape of HIF-1α expression across 24,186 solid tumors using comprehensive immune profiling
- Parikh, Hardik I.; Pabla, Sarabjot; Senosain, Maria-Fernanda; Seager, Robert; Vanroey, Erik; Gao, Shuang; Pulivendula, Yamuna; DePietro, Paul; Nesline, Mary; Dash, Durgapras; Conroy, Jeffrey; Hastings, Stephanie; Ko, Heidi; Strickland, Kyle; Previs, Rebecca; Severson, Eric; Jensen, Taylor; Ramkissoon, Shakti; Eisenberg, Marcia; Caveney, Brian; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 1OmniSeq Inc. (Labcorp Oncology), Buffalo, NY; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 2Labcorp Oncology, Durham, NC; ; 3Labcorp, Durham, NC.; 3Labcorp, Durham, NC.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.379-379)
-
34
- Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis
- Orr, A. Wayne; Stockton, Rebecca; Simmers, Michael B.; Sanders, John M.; Sarembock, Ian J.; Blackman, Brett R.; Alexander Schwartz, Martin; ; (The Journal of experimental medicine, v.204, 2007, pp.i7-i7)
-
35
- Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or <i>BRCA1/2</i> breast cancer (CRUK/07/012)
- Tutt, Andrew; Ellis, Paul; Kilburn, Lucy; Gilett, Cheryl; Pinder, Sarah; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Chan, Stephen; Cheang, Maggie; Dowsett, Mitch; Fox, Lisa; Gazinska, Patrycja; Grigoriadis, Anita; Gutin, Alexander; Harper-Wynne, Catherine; Hatton, Matthew; Kernaghan, Sarah; Lanchbury, Jerry; Morden, James; Owen, Julie; Parikh, Jyoti; Parker, Peter; Rahman, Nazneen; Roylance, Rebecca; Shaw, Adam; Smith, Ian; Thompson, Rose; Timms, Kirsten; Tovey, Holly; Wardley, Andrew; Wilson, Gregory; Harries, Mark; Bliss, Judith; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.75, 2015, pp.S3-01-S3-01)
-
36
- Abstract GS2-01: GS2-01 Trastuzumab deruxtecan vs physician’s choice in patients with HER2+ unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine: primary results of the randomized, phase 3 study DESTINY-Breast02
- Krop, Ian; Park, Yeon H.; Kim, Sung-Bae; Borges, Giuliano; Aksoy, Sercan; Gregori, Joaquin Gavila; Roylance, Rebecca; Lim, Elgene; Yerushalmi, Rinat; Zagouri, Flora; Duhoux, Francois P.; Fehm, Tanja; Takano, Toshimi; Egorov, Anton; Wu, Iris; Cathcart, Jillian; Chu, Changan; Andre, Fabrice; 1Yale School of Medicine, New Haven, Connecticut; 2Samsung Medical Center, Seoul, Republic of Korea; 3Asan Medical Center, Seoul, Republic of Korea; 4Clí nica de Neoplasias Litoral, Santa Catarina, Brazil, Brazil; 5Hacettepe University Medical School, Ankara, Turkey; 6Instituto Valenciano de Oncologia, Valencia, Spain; 7University College London Hospital, London, UK; 8St Vincent’s Hospital Sydney, Sydney, NSW, Australia; 9Rabin Medical Center-Beilinson Campus, Petah Tikva, Israel; 10General Hospital of Athens Alexandra, Athens, Greece; 11Cliniques Universitaires Saint-Luc, Bruxelles, Belgium; 12University Hospital Dü sseldorf, Dü sseldorf, Germany; 13The Cancer Institute Hospital of JFCR, Tokyo, Japan; 14Daiichi Sankyo, Inc., Basking Ridge, NJ, USA; 15Daiichi Sankyo, Inc., Basking Ridge, NJ, USA; 16Daiichi Sankyo, Inc., Basking Ridge, NJ, USA; 17Daiichi Sankyo, Inc., Basking Ridge, NJ, USA; 18Gustave Roussy, Villejuif, France.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.GS2-01-GS2-01)
-
37
- Abstract GS3-04: Double-blind placebo (PBO)-controlled randomized phase III trial evaluating first-line ipatasertib (IPAT) combined with paclitaxel (PAC) for <i>PIK3CA/AKT1/PTEN</i>-altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC): primary results from IPATunity130 Cohort A
- Dent, Rebecca; Kim, Sung-Bae; Oliveira, Mafalda; Barrios, Carlos; O’Shaughnessy, Joyce; Isakoff, Steven J; Saji, Shigehira; Freitas-Junior, Ruffo; Philco, Manuel; Bondarenko, Igor; Lian, Qinshu; Bradley, Denise; Hinton, Heather; Wongchenko, Matthew J; Mani, Aruna; Turner, Nicholas; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.GS3-04-GS3-04)
-
38
- Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis
- Orr, A. Wayne; Stockton, Rebecca; Simmers, Michael B.; Sanders, John M.; Sarembock, Ian J.; Blackman, Brett R.; Schwartz, Martin Alexander; Robert M. Berne Cardiovascular Research Center, Department of Biomedical Engineering, Department of Internal Medicine, Department of Microbiology, and Mellon Prostate Cancer Research Center, University of Virginia, Charlottesville, VA 22908; Robert M. Berne Cardiovascular Research Center, Department of Biomedical Engineering, Department of Internal Medicine, Department of Microbiology, and Mellon Prostate Cancer Research Center, University of Virginia, Charlottesville, VA 22908; Robert M. Berne Cardiovascular Research Center, Department of Biomedical Engineering, Department of Internal Medicine, Department of Microbiology, and Mellon Prostate Cancer Research Center, University of Virginia, Charlottesville, VA 22908; Robert M. Berne Cardiovascular Research Center, Department of Biomedical Engineering, Department of Internal Medicine, Department of Microbiology, and Mellon Prostate Cancer Research Center, University of Virginia, Charlottesville, VA 22908; Robert M. Berne Cardiovascul; (The Journal of cell biology, v.176, 2007, pp.719-727)
-
39
- Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer
- Kaklamani, Virginia; Bardia, Aditya; Wilks, Sharon; Weise, Amy; Richards, Donald; Harb, Wael; Osborne, Cynthia; Wesolowski, Robert; Karuturi, Meghan; Conkling, Paul; Bagley, Rebecca; Jung, JungAh; Bihani, Teeru; Conlan, Maureen; Kabos, Peter; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.PD7-07-PD7-07)
-
40
- Upper airway imaging and function in obstructive sleep apnea in people with and without HIV
- Darquenne, Chantal; Theilmann, Rebecca J.; Rivoalen, Ines; DeYoung, Pamela N.; Orr, Jeremy E.; Malhotra, Atul; Hicks, Charles B.; Owens, Robert L.; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States; Department of Radiology, University of California, San Diego, California, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, California, United States; Division of Infectious Diseases, Department of Medicine, University of California, San Diego, California, United States; Division of Pulmonary, Critical Care, and Sleep Medic; (Journal of applied physiology, v.136, 2024, pp.313-321)
QUICK MENU
